The progress in vaccines for Haemophilus influenzae type b infection is followed; it is the disadvantages of pure polysaccharide vaccines that have stimulated the development of the present generation of polysaccharide-protein conjugated vaccines.
From extensive clinical trials it is apparent that these are very effective in preventine disease in children.
Conjugated haemophilus vaccines were introduced into the routine immunization schedules in the UK in Autumn 1992.
Meningococcal A and C polysaccharide vaccines, effective for epidemic disease, are only now being developed in a protein conjugated form with the prospect of protecting young children and producing durable immunity.
Mots-clés Pascal : Article synthèse, Immunisation, Vaccination, Vaccin, Haemophilus influenzae, Pasteurellaceae, Bactérie, Epidémiologie, Royaume Uni, Europe, Méningococcie, Bactériose, Infection, Méningite, Encéphale pathologie, Système nerveux pathologie, Immunoprotection
Mots-clés Pascal anglais : Review, Immunization, Vaccination, Vaccine, Haemophilus influenzae, Pasteurellaceae, Bacteria, Epidemiology, United Kingdom, Europe, Meningococcal disease, Bacteriosis, Infection, Meningitis, Cerebral disorder, Nervous system diseases, Immunoprotection
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0302588
Code Inist : 002B05A02. Création : 199406.